Skip to main content

Table 5 Serum levels of proteins according to the diseases

From: Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis

Serum levels*

All

n = 38

PsA

n = 12

RA

n = 7

OA

n = 15

AS

n = 4

p

DKK1

pgr/mL

3525

(1841–4791)

4215

(1894–5083)

2119

(791–3746)

2807

(1265–4762)

3826

(1909–5740)

0.648

Sclerostin ngr/mL

7.08

(5.23–10.99)

6.58

(5.79–9.95)

6.42

(2.90-12.32)

9.13

(5.10–8.63)

7.58

(5.18–8.63)

0.966

BMP2

pgr/mL

70.20

(57.57–99.29)

77.79

(61.10-96.65)

99.92

(57.87-103.05)

70.77

(64.43-107.82)

44.18

(43.03–44.18)

0.043

BMP4

pgr/mL

420

(287–550)

398

(264–548)

359

(244–532)

459

(241–620)

428

(321–526)

0.139

Wnt1

(ng/mL)

0.30

(0.21–0.47)

0.30

(0.24–0.54)

0.28

(0.18–0.58)

0.32

(0.17–0.53)

0.36

(0.23–0.46)

0.508

Wnt5a

ngr/mL

55.11

(30.13–98.49)

54.84

(38.64–98.71)

37.37

(20.73–64.69)

56.93

(40.14–87.28)

68.67

(40.81–96.62)

0.767

TGFβ1

pgr/mL

1694

(1060–2038)

1551

(661–2232)

1530

(769–1871)

1529

(1015–1812)

2039

(1527–2372)

0.408

IL17A

pg/mL

510

(347–941)

429.8

(121.9-672.1)

309.2

(241.8-463.4)

877.3

(499.4–1165)

486.2

116.8-516.7

0.492

IL22

ngr/mL

39.83

(17.72–7.22)

29.91

(21.76–92.93)

41.68

(11.83–60.80)

44.92

(16.69–65.89)

73.56

(47.40-103.91)

0.141

IL6

pgr/mL

63.72

(37.70-138.61)

87.41

(56.32-144.93)

99.56

(35.94-144.42)

34.95

(52.91–66.25)

92.21

(41.15-205.19)

0.397

  1. *Data as median (Q1-Q3). Kruskal-Wallis test.